Antiandrogens: Spironolactone, flutamide, cyproterone acetate and gonadotrophin-releasing hormone inhibitors

Dermatologic Therapy

Volumn 8, Issue , 1998, Pages 63-67

  Dawber, Rodney ^b  

^a Oxford Clinical Communications   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; BUSERELIN; CYPROTERONE ACETATE; DIANE; ESTROGEN; FLUTAMIDE; FOLLITROPIN; GONADORELIN ANTAGONIST; LEUPRORELIN; LUTEINIZING HORMONE; NAFARELIN; SPIRONOLACTONE;

ACNE; ANDROGEN METABOLISM; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; HIRSUTISM; HORMONE INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; REVIEW; TREATMENT INDICATION;

EID: 0032466953     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Hammerstein J. Antiandrogens: clinical aspects: In: Orfanos EC, Happle R, ed. Hair and hair diseases. Berlin: Springer, 1989: 827-886.
2. Hammerstein J, Meckies J, Leo-Rossberg I, Moltz L, Zielske F. The use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. J Steroid Biochem 1975: 6: 827-832.
3. Goodfellow A, Alaghband-Zadeh J, Carter G, Cream JJ. Oral spironolactone improves acne vulgaris and reduces sebum excretion. Br J Dermatol 1984: 111: 209-212.
4. Peets EA, Henson MF, Neri R. On the mechanism of antiandrogenic action of flutamide. Endocrinology 1974: 94: 532-540.
5. Burke BM, Cunliffe WJ. Oral spironolactone for female patients with acne, hirsutism or androgenetic alopeica. Br J Dermatol 1985: 112: 124-125.
6. Barth, JH, Cherry CA, Wojnarowska F, Dawber RPR. Spironolactone is an effective and well Tolerated systemis antiandrogen therapy. J Clinical Endocrinol Metab 1989: 68: 966-970.
7. Ober KP, Hennessy JF. Spironolactone therapy for hirsutism in a hyperandrogenic woman. Ann Intern Med 1987: 98: 643-644.
8. Rushton H. Quantitative assessment of spironolactone treatment in women with diffuse androgen-dependant alopecia. J Soc Cosmet Chem 1991: 42: 317-325.
9. Cusan L, Dupont A, Gomez J-L, Tremblay RR, Labrie F. Treatment of hirsutism with the pure antiandrogen flutamide. J Am Acad Dermatol 1990: 23: 462-464.
10. Cusan L, Dupont A, Gomez J-L. Comparison of flutamide and spironolactone in the treatment of hirsutism. Fertility Sterility 1994: 61: 281-284.
11. Erenus M, Gürbüz O, Durmusoglu F. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism. Fertility Sterility 1994: 61: 613-615.
12. Wallace C, Lalor EA, Chik CL. Hepatotoxicity complicating Flutamide treatment of hirsutism. Ann Intern Med 1993: 118: 1150.
13. Barth JH, Cherry CA, Wojnarowska F, Dawber RPR. Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study. Clin Endocrinol (Oxf) 1991: 35: 5-9.
14. Mortimer CH, Rushton H, James KC. Effective medical treatment of common bladness in women. Clin Exp Dermatol 1984: 9: 342-344.
15. Dawber RPR, Sonnex T, Ralfs I. Oral antiandrogen treatment of common baldness in women. Br J Dermatol 1982: 107: 20-21.
16. Fugère P. Cyproterone acetate/ethinyl oestradiol in the treatment of acne. Contraception 1990: 42: 225-234.
17. Colver GB, Dawber RPR, Wojnarowska F. Cyproterone acetate and two doses of oestrogen in female ance; a double-blind comparison. Br J Dermatol 1988: 118: 95-99.
18. Mortimer PS, Dawber RPR, Gale M. Mediation of Hidradenitis suppurativa by androgens. Br Med J 1986: 292: 961-962.
19. Mortimer PS, Dawber RPR, Gale M. A double-blind cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 1986: 115: 263-268.
20. Lewis S. Warning on cyproterone. Lancet 1995: 345: 247-248.
21. Wanatabe S. Three cases of hepatocellular carcinoma among cyproterone users. Lancet 1994: 334: 1567-1568.
22. Rittmaster RS, Thompson DL. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism. J Clin Endocrinol Metab 1990: 70: 1096-1102.